A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
NCT ID: NCT06834347
This clinical trial is studying a medication called itepekimab to see how well it works for people with chronic rhinosinusitis with nasal polyps, a condition that causes long-term nasal congestion ...
Recruiting
Phase: PHASE3
Type: interventional
Locations: Montreal, Quebec, Canada, Seoul, Seoul Teukbyeolsi, Korea, Republic Of +23 more